SCHEMBL26093057

SCHEMBL26093057

CC(C)CC(=O)N1CCNc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 4/20 0.51
THRB P10828 1/20 0.44
HSD17B3 P37058 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
HSD11B1 P28845 1/20 0.41
GAA P10253 3/20 0.40
KMT2A Q03164 2/20 0.40
GPBAR1 Q8TDU6 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
ADAM17 P78536 1/20 0.39
CASP3 P42574 1/20 0.39
CASP2 P42575 1/20 0.39
AVPR2 P30518 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30910105 1.00 AVPR1A (0.51) AVPR1ATHRBHSD17B3L3MBTL1HSD11B1
SCHEMBL22049116 0.84 AVPR1A (0.54) AVPR1ATHRBHSD17B3HSD11B1GAA
SCHEMBL25937281 0.82 AVPR1A (0.52) AVPR1ATHRBHSD17B3HSD11B1GAA
SCHEMBL26092817 0.80 AVPR1A (0.51) AVPR1ATHRBHSD17B3HSD11B1GAA
SCHEMBL30673903 0.80 AVPR1A (0.51) AVPR1ATHRBHSD17B3HSD11B1GAA
SCHEMBL28092508 0.80 P2RX4 (0.49) AVPR1ATHRBHSD17B3L3MBTL1HSD11B1
SCHEMBL30529514 0.79 HSD17B3 (0.60) AVPR1AHSD17B3HSD11B1GAAGPBAR1
SCHEMBL3115822 0.79 HSD17B3 (0.60) AVPR1AHSD17B3HSD11B1GAAGPBAR1
SCHEMBL20571673 0.78 THRB (0.54) AVPR1ATHRBHSD17B3L3MBTL1HSD11B1
SCHEMBL30254663 0.78 AVPR1A (0.54) AVPR1ATHRBHSD17B3HSD11B1GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025127848-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 사피엔스바이오 2025-06-19 WO disclosed
EP-4538270-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT Sapiensbio Inc. (KR) 2025-04-16 EP disclosed
CN-118119612-A Novel compounds and pharmaceutical compositions comprising the same 萨皮恩斯生物有限公司 2024-05-31 CN disclosed
WO-2023239227-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 사피엔스바이오 2023-12-14 WO disclosed
WO-2023068755-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 사피엔스바이오 2023-04-27 WO disclosed